Results 201 to 210 of about 7,174,113 (351)
Single circulating tumor cells (sCTCs) from high‐grade serous ovarian cancer patients were enriched, imaged, and genomically profiled using WGA and NGS at different time points during treatment. sCTCs revealed enrichment of alterations in Chromosomes 2, 7, and 12 as well as persistent or emerging oncogenic CNAs, supporting sCTC identity.
Carolin Salmon +9 more
wiley +1 more source
Analyzing the citation impact of predatory journals in the health sciences. [PDF]
Watson E, Zhang L.
europepmc +1 more source
Abstracts of the 32nd Annual Meeting of the UOEH Association of Health Sciences
産業医科大学
openalex +2 more sources
Methods to improve antibody–drug conjugate (ADC) treatment durability in cancer therapy are needed. We utilized ADCs and immune‐stimulating antibody conjugates (ISACs), which are made from two non‐competitive antibodies, to enhance the entry of toxic payloads into cancer cells and deliver immunostimulatory agents into immune cells.
Tiexin Wang +3 more
wiley +1 more source
Epidemiology and risk factors of migraine and TTH in Sudanese health sciences students. [PDF]
Nasr RMH +9 more
europepmc +1 more source
‘The industry must be inconspicuous’ : Japan Tobacco’s corruption of science and health policy via the Smoking Research Foundation [PDF]
香穂里 飯田 +1 more
openalex
Etoposide induces DNA damage, activating p53‐dependent apoptosis via caspase‐3/7, which cleaves PARP1. Dammarenediol II enhances this apoptotic pathway by suppressing O‐GlcNAc transferase activity, further decreasing O‐GlcNAcylation. The reduction in O‐GlcNAc levels boosts p53‐driven apoptosis and influences the Akt/GSK3β/mTOR signaling pathway ...
Jaehoon Lee +8 more
wiley +1 more source
Communicating Environmental Health Science Effectively to the Public [PDF]
David T. Dyjack +2 more
openalex +1 more source

